Agility, Elekta’s Innovative Beam-Shaping Solution for Cancer Treatment, Ships Globally

        Print
| Source: Elekta AB
Stockholm, Sweden, October 22, 2012 – In the last six months, cancer clinics in
21 countries have accepted delivery of Elekta’s Agility™*, an innovative, ground
-breaking 160-leaf multi-leaf collimator (MLC) that utilizes industry-leading
technology to provide faster, more accurate, and more versatile radiation
therapy for individuals with cancer.
Agility was recently introduced at Radboud University Nijmegen Medical Center
(Nijmegen, Netherlands), where a 48-year-old woman, was treated on September 10.

“Our first use of Agility went perfectly – the high leaf speed of Agility has
made beam delivery speed much faster, especially with IMRT (Intensity Modulated
Radiation Therapy) plans,” says René Monshouwer, Ph.D., Clinical Physicist at
Radboud. “And, comparing the system with Agility to one without Agility, the
leaf transmission is lower. Since we began, we have used Agility for 70
patients, encompassing a wide range of cancers throughout the body.”

Monshouwer also noted that Agility’s low transmission and high-resolution leaves
will enable Radboud to use Agility in stereotactic treatments in the coming
months.

Legacy Mount Hood Medical Center (Gresham, OR, USA) is the latest site to date
to accept shipment of Agility, integrated in a newly acquired Elekta Infinity™
treatment system. According to Kathryn Panwala, M.D., a radiation oncologist at
Legacy, she and her colleagues are eagerly anticipating the patient benefits
Agility will bring.

“We’re looking forward to the ability to use the five millimeter interdigitating
leaves in Agility to allow us to sculpt the radiation dose even more precisely,
reduce potential treatment complications and – by virtue of the MLC’s low
transmission – reduce unnecessary radiation exposure to normal tissues. We
anticipate improved outcomes for our patients with our ability to accurately
hypofractionate targets,” she says. “We also are looking ahead to doing more
complicated treatments at the Mount Hood facility with Agility – so SBRT and SRT
cases that we had been sending to our downtown facility will be performed at
Mount Hood, which is much more convenient for patients. Of course, we also
expect treatment times will be faster with the higher speed of leaf movements.”

Intelligent beam shaping

Among MLCs, Agility is in class by itself – combining leaf speeds that are twice
as fast as conventional beam-shaping devices. The 160 leaves of Agility are 5 mm
in width at isocenter and are capable of interdigitation to enable treatment of
island fields and multiple targets in a single session. Rubicon optical leaf
positioning technology improves accuracy and increases the reliability and
seamlessness of beam shaping, and the exceptionally low leaf transmission of
less than 0.5 percent enhances treatment delivery while reducing integral dose.
The integrated whole results in a sophisticated, multi-functional beam-shaping
solution.

Learn more about Agility at www.elekta.com/agility.

*Agility is not available for sale or distribution in all markets. Please
contact the local Elekta representative for details.

# # #

For further information, please contact:

Johan Andersson Melbi, Director, Investor Relations, Elekta AB

Tel: +46 702 100 451, email: johan.anderssonmelbi@elekta.com

Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta

Tel: +1 770-670-2447, email: michelle.joiner@elekta.com

Time zone: ET: Eastern Time

The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on October 22, 2012.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both healthcare providers and patients,
Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,400 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.